SPYRE THERAPEUTICS, INC. Defined Contribution Plan, Employer Discretionary Contribution Amount
SPYRE THERAPEUTICS, INC. (SYRE) reported Defined Contribution Plan, Employer Discretionary Contribution Amount of $600.00 thousand for the 12-month period ending 2022-12-31, per its 10-K filed 2023-03-02.
Discontinued › Notes › Compensation Related Costs
us-gaap:DefinedContributionPlanEmployerDiscretionaryContributionAmount · last filed 2023-03-02
- SPYRE THERAPEUTICS, INC. defined contribution plan, employer discretionary contribution amount for fiscal 2022 was $600.00K, a 0.00% change from fiscal 2021.
- SPYRE THERAPEUTICS, INC. defined contribution plan, employer discretionary contribution amount for fiscal 2021 was $600.00K, a 20.00% increase from fiscal 2020.
- SPYRE THERAPEUTICS, INC. defined contribution plan, employer discretionary contribution amount for fiscal 2020 was $500.00K, a 66.67% increase from fiscal 2019.
- SPYRE THERAPEUTICS, INC. defined contribution plan, employer discretionary contribution amount for fiscal 2019 was $300.00K, a 50.00% increase from fiscal 2018.
| Period end | Defined Contribution Plan, Employer Discretionary Contribution Amount 12 month | Defined Contribution Plan, Employer Discretionary Contribution Amount 12 month as first filed |
|---|---|---|
| 2022-12-31 | $600.00K 10-K · filed 2023-03-02 | |
| 2021-12-31 | $600.00K 10-K · filed 2023-03-02 | |
| 2020-12-31 | $500.00K 10-K · filed 2023-03-02 | |
| 2019-12-31 | $300.00K 10-K · filed 2022-03-08 | |
| 2018-12-31 | $200.00K 10-K · filed 2021-03-18 | |
| 2017-12-31 | $100.00K 10-K · filed 2020-02-24 | $135.00K 10-K · filed 2018-03-13 |
| 2016-12-31 | $100.00K 10-K · filed 2019-03-07 | $51.00K 10-K · filed 2017-03-23 |
| 2015-12-31 | $0.00 10-K · filed 2018-03-13 | |
| 2014-12-31 | $0.00 10-K · filed 2017-03-23 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Structure Therapeutics Inc. (GPCR) | United States | $7.710B | -53.41 |
| Praxis Precision Medicines, Inc. (PRAX) | United States | $7.884B | -27.60 |
| IONIS PHARMACEUTICALS INC (IONS) | United States | $7.277B | -23.25 |
| Alkermes plc. (ALKS) | $6.844B | 132.74 | |
| RHYTHM PHARMACEUTICALS, INC. (RYTM) | United States | $6.771B | -37.20 |
| TG THERAPEUTICS, INC. (TGTX) | United States | $8.805B | 19.05 |
| Protagonist Therapeutics, Inc (PTGX) | United States | $8.883B | 95.52 |
| Liquidia Corp (LQDA) | United States | $6.347B | 51.23 |
| Amneal Pharmaceuticals, Inc. (AMRX) | $6.326B | 25.62 | |
| CYTOKINETICS INC (CYTK) | United States | $9.130B | -11.86 |